Literature DB >> 14500783

A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity.

Michael H Shaw1, Victor Boyartchuk, Sandy Wong, Marina Karaghiosoff, Josiane Ragimbeau, Sandra Pellegrini, Mathias Muller, William F Dietrich, George S Yap.   

Abstract

The B10.Q/J strain of mice was serendipitously discovered to be highly susceptible to infection by the intracellular protozoan parasite, Toxoplasma gondii but markedly resistant to induction of autoimmune arthritis. We have previously shown that the B10.Q/J phenotype is controlled by a single recessive locus and is associated with lymphocyte hyporesponsiveness to IL-12. Using genetic approaches, we have now localized the B10.Q/J locus to chromosome 9 and established its identity as Tyk2, a Janus kinase essential for IL-12 and IFN-alpha/beta cytokine signaling. The B10.Q/J Tyk2 gene contained a single missense mutation resulting in a nonconservative amino acid substitution (E775K) in an invariant motif of the pseudokinase (Janus kinase homology 2) domain. This mutation appeared to result in the absence of the B10.Q/J-encoded Tyk2 protein, despite presence of Tyk2-specific transcripts. Phenotypically, B10.Q/J cells were indistinguishable from Tyk2-deficient cells, showing impaired signaling and biologic responses to IL-12, IL-23, and type I IFNs. The analogous E782K mutant of human Tyk2 failed to restore IFN-alpha responsiveness in Tyk2 null 11,1 cells. Our results indicate a crucial role for Tyk2 in T helper 1-mediated protective and pathogenic immune responses. An additional implication of our findings is that naturally occurring mutations in the Tyk2 gene may underlie altered susceptibilities to infectious or autoimmune diseases in human and animal populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500783      PMCID: PMC208803          DOI: 10.1073/pnas.1930781100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.

Authors:  Tom H M Ottenhoff; Frank A W Verreck; Elgin G R Lichtenauer-Kaligis; Marieke A Hoeve; Ozden Sanal; Jaap T van Dissel
Journal:  Nat Genet       Date:  2002-09       Impact factor: 38.330

2.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

Authors:  E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

3.  Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation.

Authors:  S Dupuis; C Dargemont; C Fieschi; N Thomassin; S Rosenzweig; J Harris; S M Holland; R D Schreiber; J L Casanova
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

4.  Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis.

Authors:  F Altare; A Ensser; A Breiman; J Reichenbach; J E Baghdadi; A Fischer; J F Emile; J L Gaillard; E Meinl; J L Casanova
Journal:  J Infect Dis       Date:  2001-06-14       Impact factor: 5.226

Review 5.  Genetic dissection of immunity to mycobacteria: the human model.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.

Authors:  Christi Parham; Madaline Chirica; Jacqueline Timans; Elena Vaisberg; Marilyn Travis; Jeanne Cheung; Stefan Pflanz; Rebecca Zhang; Komal P Singh; Felix Vega; Wayne To; Janet Wagner; Anne-Marie O'Farrell; Terrill McClanahan; Sandra Zurawski; Charles Hannum; Daniel Gorman; Donna M Rennick; Robert A Kastelein; Rene de Waal Malefyt; Kevin W Moore
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.

Authors:  J Feng; B A Witthuhn; T Matsuda; F Kohlhuber; I M Kerr; J N Ihle
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

8.  STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation.

Authors:  Akio Morinobu; Massimo Gadina; Warren Strober; Roberta Visconti; Albert Fornace; Cristina Montagna; Gerald M Feldman; Ryuta Nishikomori; John J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

9.  Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.

Authors:  T M Scharton-Kersten; G Yap; J Magram; A Sher
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

10.  Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

Authors:  Marie-Laure Santiago-Raber; Roberto Baccala; Katarina M Haraldsson; Divaker Choubey; Timothy A Stewart; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  44 in total

Review 1.  Targeting the Jak/STAT pathway for immunosuppression.

Authors:  J J O'shea
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

2.  Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.

Authors:  Melissa G Works; Fangfang Yin; Catherine C Yin; Ying Yiu; Kenneth Shew; Thanh-Thuy Tran; Nahoko Dunlap; Jennifer Lam; Tim Mitchell; John Reader; Paul L Stein; Annalisa D'Andrea
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

Review 3.  Therapeutic targeting of Janus kinases.

Authors:  Marko Pesu; Arian Laurence; Nandini Kishore; Samuel H Zwillich; Gary Chan; John J O'Shea
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 4.  Regulation and function of IL-17A- and IL-22-producing γδ T cells.

Authors:  Kristin J Ness-Schwickerath; Craig T Morita
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

Review 5.  Role of type I interferons in the activation of autoreactive B cells.

Authors:  Kerstin Kiefer; Michael A Oropallo; Michael P Cancro; Ann Marshak-Rothstein
Journal:  Immunol Cell Biol       Date:  2012-03-20       Impact factor: 5.126

Review 6.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

7.  Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.

Authors:  Allan J Bieber; Kanitta Suwansrinon; Jason Kerkvliet; Weidong Zhang; Larry R Pease; Moses Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

Review 9.  Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice.

Authors:  Silvia Bolland; Adolfo Garcia-Sastre
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

10.  A single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitis.

Authors:  Karen M Spach; Rajkumar Noubade; Ben McElvany; William F Hickey; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.